Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.Medidata is a registered trademark of Medidata Solutions, Inc., a wholly owned subsidiary of Dassault Systèm.

Visit medidata.com

Find out more

What is impossible? Reversing blindness with a virus? Curing a rare disease in a pandemic? Today’s impossible is tomorrow’s standard of care. For over twenty years, we’ve been redefining what’s possible in clinical trials. So bring us your impossible challenges, and we’ll solve them together.

For more information on partnership opportunities at other FT Live events, get in touch today to see how you can get involved.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice